What do the latest NICE guidelines mean for you? (C-60353)
Since October 2017, NICE has issued two new clinical guidelines and one update concerning the three most common age-related causes of sight loss. Madeleine Bailey looks at what it means for you – and NHS eye services overall
With the number of people in the UK living with reduced vision predicted to almost double to four million by 2050, and nearly nine million currently treated annually by hospital eye services (RCOphth, 2016), there has never been a greater need for updated clinical guidelines and an ironing out of inconsistencies in treatment for cataract, age-related macular degeneration (AMD) and glaucoma. NICE guidelines are based on the best available evidence, with a reputation for rigour, independence and objectivity, and are considered to be the gold standard for clinical practice and cost-effectiveness.
Login to read the rest of this article.
Not already a member of the College?
Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.
Related further reading
Our Clinical Adviser comments on the story in the BBC about the woman who had gene therapy to try to halt the progression of age-related macular degeneration (AMD).
Our Clinical Adviser offers his advice, following an article by The Express on the best supplements for eyes.
College comments on BBC’s article on lens replacement leading to 'blind patches’.